Search

Your search keyword '"van Rheenen, Wouter"' showing total 502 results

Search Constraints

Start Over You searched for: Author "van Rheenen, Wouter" Remove constraint Author: "van Rheenen, Wouter"
502 results on '"van Rheenen, Wouter"'

Search Results

1. Diagnosing primary lateral sclerosis: a clinico-pathological study

2. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

3. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

4. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

5. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

6. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases

7. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors

8. Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy

9. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

10. Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

11. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia

12. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

13. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

15. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

16. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

18. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.

19. Assessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion

20. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

23. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.

24. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

25. Assessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion.

27. Associations of autozygosity with a broad range of human phenotypes

28. Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis

29. Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis

30. Genetic variability in sporadic amyotrophic lateral sclerosis

31. Clinical testing panels for ALS : global distribution, consistency, and challenges

32. Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors

33. Genetic variability in sporadic amyotrophic lateral sclerosis

34. Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis: A Meta-analysis and Population-Based Study

35. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

36. Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

37. UNC13A in amyotrophic lateral sclerosis: From genetic association to therapeutic target

38. Genetic variability in sporadic amyotrophic lateral sclerosis

40. UNC13Ain amyotrophic lateral sclerosis: from genetic association to therapeutic target

41. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

43. Slow Channel Syndrome Revisited: 40 Years Clinical Follow-Up and Genetic Characterization of Two Cases

44. Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data

45. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort

46. UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target.

47. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis

48. Clinical testing panels for ALS: global distribution, consistency, and challenges

49. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials

50. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

Catalog

Books, media, physical & digital resources